Biotechnology Portfolio Biotechnology Fund Volatility
| FBIOX Fund | USD 17.72 0.14 0.78% |
Biotechnology Portfolio secures Sharpe Ratio (or Efficiency) of -0.0066, which signifies that the fund had a -0.0066% return per unit of risk over the last 3 months. Biotechnology Portfolio Biotechnology exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Biotechnology Portfolio's Risk Adjusted Performance of (0.01), mean deviation of 1.11, and Standard Deviation of 1.37 to double-check the risk estimate we provide. Key indicators related to Biotechnology Portfolio's volatility include:
30 Days Market Risk | Chance Of Distress | 30 Days Economic Sensitivity |
Biotechnology Portfolio Mutual Fund volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Biotechnology daily returns, and it is calculated using variance and standard deviation. We also use Biotechnology's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Biotechnology Portfolio volatility.
Biotechnology |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Biotechnology Portfolio can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Biotechnology Portfolio at lower prices. For example, an investor can purchase Biotechnology stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Biotechnology Portfolio's stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.
Moving together with Biotechnology Mutual Fund
| 0.76 | FPTKX | Fidelity Freedom 2015 | PairCorr |
| 0.7 | FPURX | Fidelity Puritan | PairCorr |
| 0.7 | FPUKX | Fidelity Puritan | PairCorr |
| 0.64 | FPXTX | Fidelity Pennsylvania | PairCorr |
| 0.71 | FQIFX | Fidelity Freedom Index | PairCorr |
| 0.74 | FQIPX | Fidelity Freedom Index | PairCorr |
| 0.88 | FQITX | Fidelity Salem Street | PairCorr |
| 0.71 | FQLSX | Fidelity Flex Freedom | PairCorr |
| 0.73 | FRAGX | Aggressive Growth | PairCorr |
Biotechnology Portfolio Market Sensitivity And Downside Risk
Biotechnology Portfolio's beta coefficient measures the volatility of Biotechnology mutual fund compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Biotechnology mutual fund's returns against your selected market. In other words, Biotechnology Portfolio's beta of 1.39 provides an investor with an approximation of how much risk Biotechnology Portfolio mutual fund can potentially add to one of your existing portfolios. Biotechnology Portfolio Biotechnology exhibits very low volatility with skewness of 0.07 and kurtosis of -0.09. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Biotechnology Portfolio's mutual fund risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Biotechnology Portfolio's mutual fund price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Biotechnology Portfolio Demand TrendCheck current 90 days Biotechnology Portfolio correlation with market (NYSE Composite)Biotechnology Beta |
Biotechnology standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 1.39 |
It is essential to understand the difference between upside risk (as represented by Biotechnology Portfolio's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Biotechnology Portfolio's daily returns or price. Since the actual investment returns on holding a position in biotechnology mutual fund tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Biotechnology Portfolio.
Biotechnology Portfolio Mutual Fund Volatility Analysis
Volatility refers to the frequency at which Biotechnology Portfolio fund price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Biotechnology Portfolio's price changes. Investors will then calculate the volatility of Biotechnology Portfolio's mutual fund to predict their future moves. A fund that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A mutual fund with relatively stable price changes has low volatility. A highly volatile fund is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Biotechnology Portfolio's volatility:
Historical Volatility
This type of fund volatility measures Biotechnology Portfolio's fluctuations based on previous trends. It's commonly used to predict Biotechnology Portfolio's future behavior based on its past. However, it cannot conclusively determine the future direction of the mutual fund.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Biotechnology Portfolio's current market price. This means that the fund will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Biotechnology Portfolio's to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Biotechnology Portfolio Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Biotechnology Portfolio Projected Return Density Against Market
Assuming the 90 days horizon the mutual fund has the beta coefficient of 1.3865 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Biotechnology Portfolio will likely underperform.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Biotechnology Portfolio or Fidelity Investments sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Biotechnology Portfolio's price will be affected by overall mutual fund market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Biotechnology fund's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Biotechnology Portfolio Biotechnology has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite. Predicted Return Density |
| Returns |
What Drives a Biotechnology Portfolio Price Volatility?
Several factors can influence a fund's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Biotechnology Portfolio Mutual Fund Risk Measures
Assuming the 90 days horizon the coefficient of variation of Biotechnology Portfolio is -15159.79. The daily returns are distributed with a variance of 1.94 and standard deviation of 1.39. The mean deviation of Biotechnology Portfolio Biotechnology is currently at 1.12. For similar time horizon, the selected benchmark (NYSE Composite) has volatility of 0.63
α | Alpha over NYSE Composite | -0.11 | |
β | Beta against NYSE Composite | 1.39 | |
σ | Overall volatility | 1.39 | |
Ir | Information ratio | -0.07 |
Biotechnology Portfolio Mutual Fund Return Volatility
Biotechnology Portfolio historical daily return volatility represents how much of Biotechnology Portfolio fund's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The fund shows 1.3911% volatility of returns over 90 . By contrast, NYSE Composite accepts 0.6171% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Biotechnology Portfolio Volatility
Volatility is a rate at which the price of Biotechnology Portfolio or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Biotechnology Portfolio may increase or decrease. In other words, similar to Biotechnology's beta indicator, it measures the risk of Biotechnology Portfolio and helps estimate the fluctuations that may happen in a short period of time. So if prices of Biotechnology Portfolio fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.The fund invests primarily in common stocks. It normally invests at least 80 percent of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuers financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified.
Biotechnology Portfolio's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Biotechnology Mutual Fund over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Biotechnology Portfolio's price varies over time.
3 ways to utilize Biotechnology Portfolio's volatility to invest better
Higher Biotechnology Portfolio's fund volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Biotechnology Portfolio fund is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Biotechnology Portfolio fund volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Biotechnology Portfolio investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Biotechnology Portfolio's fund can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Biotechnology Portfolio's fund relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Biotechnology Portfolio Investment Opportunity
Biotechnology Portfolio Biotechnology has a volatility of 1.39 and is 2.24 times more volatile than NYSE Composite. 12 percent of all equities and portfolios are less risky than Biotechnology Portfolio. You can use Biotechnology Portfolio Biotechnology to protect your portfolios against small market fluctuations. The mutual fund experiences a moderate downward daily trend and can be a good diversifier. Check odds of Biotechnology Portfolio to be traded at $17.37 in 90 days.Poor diversification
The correlation between Biotechnology Portfolio Biotec and NYA is 0.64 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Portfolio Biotec and NYA in the same portfolio, assuming nothing else is changed.
Biotechnology Portfolio Additional Risk Indicators
The analysis of Biotechnology Portfolio's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Biotechnology Portfolio's investment and either accepting that risk or mitigating it. Along with some common measures of Biotechnology Portfolio mutual fund's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.02) | |||
| Mean Deviation | 1.11 | |||
| Coefficient Of Variation | (3,621) | |||
| Standard Deviation | 1.37 | |||
| Variance | 1.88 | |||
| Information Ratio | (0.07) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential mutual funds, we recommend comparing similar funds with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Biotechnology Portfolio Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Biotechnology Portfolio as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Biotechnology Portfolio's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Biotechnology Portfolio's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Biotechnology Portfolio Biotechnology.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Biotechnology Portfolio Biotechnology. Also, note that the market value of any mutual fund could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.